Question: In developing a vaccine for the SARS virus, a pharmaceutical company incurs a very high fixed cost. The marginal cost of delivering the vaccine to
a. Draw a diagram that shows the price for the vaccine that would arise if the company is unregulated, and label it PM. What is the efficient price for the vaccine? Show the deadweight loss that arises from the price PM.
b. On another diagram, show the lowest price that the regulator can enforce that would still induce the pharmaceutical company to develop the vaccine. Label it P*.
Show the deadweight loss that arises from this price. How does it compare to the deadweight loss that arises from the price PM?
c. Suppose you have accurate information about the pharmaceutical company's fixed cost. How could you use price regulation of the pharmaceutical company, combined with a subsidy to the company, to have the efficient quantity of the vaccine provided at the lowest cost to the government?
Step by Step Solution
3.36 Rating (171 Votes )
There are 3 Steps involved in it
a If the company is unregulated it will behave like a monopolist and choose a quantity Q M at which ... View full answer
Get step-by-step solutions from verified subject matter experts
Document Format (1 attachment)
721-B-E-E-P (1443).docx
120 KBs Word File
